-
J. Bone Miner. Res. · Apr 2009
Randomized Controlled Trial Multicenter StudyOnce-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.
- Steven Boonen, Eric S Orwoll, Dietrich Wenderoth, Karen J Stoner, Rachelle Eusebio, and Pierre D Delmas.
- Leuven University Center for Metabolic Bone Diseases, Division of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium. steven.boonen@uz.kuleuven.ac.be
- J. Bone Miner. Res. 2009 Apr 1; 24 (4): 719-25.
AbstractMale osteoporosis is increasingly recognized as a major public health issue. This multinational, 2-yr, randomized, double-blind, placebo-controlled study was conducted to determine the efficacy and safety of 35 mg once-a-week risedronate in men with osteoporosis. Patients had to be men >or=30 yr old, with lumbar spine T-score
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..